37 / 56
HIPERTENSION / 2013 / VOL. 18
35
Bibliografía
1. Garrison RJ, Kannel WB, Stokes J. Incidence and precursors of hypertension in young adults: The Framingham offspring study* 1. Preventive medicine 1987;16:235-251.
2. Kotchen TA. Obesity-Related Hypertension? Weighing the Evidence. Hypertension 2008;52:801.
3. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994;74:761-811.
4. Engeli S, Gorzelniak K, Kreutz R, et al. Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 1999;17:555-560.
5. Kotsis V, Stabouli S, Papakatsika S, Mechanisms of obesity-induced hypertension. Hypertens Res 2010;33:386-393.
6. Gordon RD, Stowasser M, Tunyy TJ, et al. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol
1994;21:315-318.
7. Calhoun DA, Jones D, Textor S, et al. Resistant Hypertension Diagnosis, Evaluation, and Treatment. A Scientific Statement From the American Heart Association
Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008;51:1403-1419.
8. Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens 2003;16:925-930.
9. Rocha R, Stier CT. Pathophysiological effects of aldosterone in cardiovascular tissues. Trends Endocrinol Metab 2001;12:308-314.
10. Goodfriend TL, Egan BM, Kelley DE. Aldosterone in obesity. Endocr Res 1998;24:789-796.
11. Caprio M, Feve B, Claes A, et al. Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J 2007;21:2185-2121.
12. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, et al. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci USA 2003;100:14211-
14216.
13. Gami AS, Caples SM, Somers VK: Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am 2003;32:869-894.
14. Pillar G, Shehadeh N. Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care 2008;31 Suppl 2:S303-309.
15. Silverberg DS, Oksenberg A, Laina A. Sleep-related breathing disorders as a major cause of essential hypertension: fact or fiction? Curr Opin Nephrol Hypertens
1998;7:353-357.
16. Fletcher EC, DeBehnke RD, Lovoi MS, et al. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 1985;103:190-195.
17. Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001;19:2271-2277.
18. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with
continuous postiive airway pressure: an observational study. JAMA 2012;307:2169-2176.
19. Dernaika TA, Kinasewitz GT, Tawk MM. Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive
sleep apnea. J Clin Sleep Med 2009;5:103-107.
20. Noria SF, Grantcharov T. Biological effects of bariatric surgery on obesity-related comorbidities. Can J Surg 2013;56:47-57.